MYGN
Myriad Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -7.1% ·
Aktienfluss +10.4% ·
neue Nettopositionen -7.7%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | -5 | 70.39M | $401.85M | +6 | −11 |
| Q1 2026 | 92 | -3 | 73.19M | $329.45M | +3 | −6 |
| Q4 2025 | 95 | 0 | 80.50M | $495.06M | — | — |
| Q3 2025 | 19 | 0 | 56.51M | $408.57M | — | — |
| Q2 2025 | 16 | 0 | 51.45M | $273.22M | +1 | −1 |
| Q1 2025 | 13 | 0 | 25.12M | $222.86M | +1 | −1 |
| Q4 2024 | 13 | -1 | 27.01M | $370.33M | — | −1 |
| Q3 2024 | 13 | +3 | 18.94M | $518.67M | +3 | — |
| Q2 2024 | 10 | — | 22.76M | $556.69M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.00M | -10.6% | $82.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.00M | -10.6% | $82.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.00M | -10.6% | $82.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.00M | -10.6% | $82.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.00M | -10.6% | $82.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passiv) | 5.53M | — | $75.76M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 4.35M | -16.1% | $59.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Glenview Capital ✦ | 4.16M | +229.6% | $57.00M | 1.4% | ▲ Add | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 2.14M | -0.5% | $29.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 2.14M | -0.5% | $29.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.82M | +58.0% | $24.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.82M | +58.0% | $24.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 905.21K | +50.2% | $12.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 765.24K | +1024.3% | $10.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 765.24K | +1024.3% | $10.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 684.87K | +87.4% | $9.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 348.60K | -67.2% | $4.78M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 153.06K | -13.8% | $2.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 114.39K | +285.0% | $1.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 114.39K | +285.0% | $1.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 114.39K | +285.0% | $1.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 44.09K | -18.9% | $605,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Marshall Wace | $3.13M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 200 Inhaber, 87.60M Anteile, $371.14M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.